Ralf Kuriyel - Jun 10, 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Senior VP, R&D
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Jun 10, 2021
Transactions value $
-$1,044,703
Form type
4
Date filed
6/14/2021, 06:48 PM
Previous filing
May 18, 2021
Next filing
Sep 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $152K +2.56K +10.41% $59.52 27.1K Jun 10, 2021 Direct
transaction RGEN Common Stock Options Exercise $90K +1.05K +3.85% $86.10 28.2K Jun 10, 2021 Direct
transaction RGEN Common Stock Sale -$1.29M -6.8K -24.16% $189.19 21.4K Jun 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 -2.56K -65.38% $0.00 1.35K Jun 10, 2021 Common Stock 2.56K $59.52 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 -1.05K -33.31% $0.00 2.09K Jun 10, 2021 Common Stock 1.05K $86.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $189.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.70 to $189.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 2,707 of the shares underlying the option have vested. The remaining 1,354 shares shall vest on February 28, 2022.
F3 1,045 of the shares underlying the option have vested. The remaining shares vest as follows: 1,046 shares on February 27, 2022 and February 27, 2023.